Vemurafenib Completed Phase 1 Trials for Malignant Melanoma, Neoplasms Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT01844674A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies